Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-07-28 5:06 pm Purchase | 13D | OncoCyte Corporation OCX | BROADWOOD PARTNERS L.P. | 30,212,899 24.1% | 6,437,935 (+27.08%) | View |
| 2022-04-15 5:21 pm Purchase | 13D | OncoCyte Corporation OCX | BROADWOOD PARTNERS L.P. | 23,774,964 19.99% | 5,939,374 (+33.30%) | View |
| 2022-03-25 5:23 pm Purchase | 13D | Lineage Cell Therapeutics, Inc. LCTX | BROADWOOD PARTNERS L.P. | 35,227,273 20.7% | 980,106 (+2.86%) | View |
| 2021-10-01 4:59 pm Sale | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS L.P. | 8,617,907 18.2% | -408,350 (-4.52%) | View |
| 2021-09-24 4:40 pm Unchanged | 13D | OncoCyte Corporation OCX | BROADWOOD PARTNERS L.P. | 17,835,590 19.3% | 0 (Unchanged) | View |
| 2021-06-15 8:46 pm Sale | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS L.P. | 9,026,257 19.2% | -443,734 (-4.69%) | View |
| 2021-04-05 5:12 pm Sale | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS L.P. | 9,469,991 20.3% | -455,931 (-4.59%) | View |
| 2021-03-16 5:04 pm Purchase | 13D | Lineage Cell Therapeutics, Inc. LCTX | BROADWOOD PARTNERS L.P. | 34,247,167 21.2% | 335,268 (+0.99%) | View |
| 2021-02-09 5:10 pm Purchase | 13D | OncoCyte Corporation OCX | BROADWOOD PARTNERS L.P. | 17,835,590 20.1% | 600,000 (+3.48%) | View |
| 2021-01-28 5:25 pm Sale | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS L.P. | 9,925,922 21.5% | -895,326 (-8.27%) | View |
| 2021-01-22 4:18 pm Purchase | 13D | OncoCyte Corporation OCX | BROADWOOD PARTNERS L.P. | 17,235,590 21.6% | 5,078,217 (+41.77%) | View |
| 2020-08-12 5:05 pm Sale | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS L.P. | 10,821,248 23.6% | -59,831 (-0.55%) | View |
| 2019-09-13 5:08 pm Purchase | 13D | OncoCyte Corporation OCX | BROADWOOD PARTNERS L.P. | 12,157,373 22.9% | 2,000,000 (+19.69%) | View |
| 2019-07-02 5:09 pm Purchase | 13D | OncoCyte Corporation OCX | BROADWOOD PARTNERS L.P. | 10,157,373 19.2% | 1,000,000 (+10.92%) | View |
| 2019-03-12 5:02 pm Purchase | 13D | Lineage Cell Therapeutics Inc. BTX | BROADWOOD PARTNERS L.P. | 33,911,899 22.4% | 6,579,737 (+24.07%) | View |
| 2019-03-12 4:50 pm Sale | 13D | Asterias Biotherapeutics Inc. AST | BROADWOOD PARTNERS L.P. | 0 0% | -4,028,053 (Position Closed) | View |
| 2019-02-12 5:16 pm Purchase | 13D | OncoCyte Corporation OCX | BROADWOOD PARTNERS L.P. | 9,157,373 17.5% | 533,333 (+6.18%) | View |
| 2018-12-10 4:15 pm Purchase | 13G | AgeX Therapeutics, Inc. AGE | BROADWOOD PARTNERS L.P. | 3,003,446 8.4% | 3,003,446 (New Position) | View |
| 2018-08-10 5:25 pm Purchase | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS L.P. | 10,881,079 24.8% | 14,144 (+0.13%) | View |
| 2018-03-30 4:35 pm Purchase | 13D | OncoCyte Corporation OCX | BROADWOOD PARTNERS L.P. | 8,624,040 21.3% | 4,453,897 (+106.80%) | View |